The global stem cell manufacturing market size reached US$ 13.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 25.0 Billion by 2032, exhibiting a growth rate (CAGR) of 7.1% during 2024-2032. More Info:- https://www.imarcgroup.com/stem-cell-manufacturing-market

1. Global Stem Cell
Manufacturing Market
Research and Forecast
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved

2. About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on management
strategy and market research worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their most critical challenges, and
transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods
are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting
results.

3. Report Highlight
and Description
According to the latest report by IMARC Group, titled "Stem Cell
Manufacturing Market: Global Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2024-2032," the global stem cell manufacturing
market size reached US$ 13.3 Billion in 2023.
Stem cells are unique types of undifferentiated cells in the human body that
can develop into various specialized cell types. They have the potential to
repair and regenerate damaged tissues and organs. They are commonly
sourced from blood, bone marrow, umbilical cord, embryo, and placenta.
Stem cells can be broadly categorized into embryonic and adult stem cells,
offering distinct advantages and applications. Stem cells play a crucial role in
tissue repair, regeneration, and maintaining the body's cellular balance.
Moreover, they are widely used to treat various diseases, such as severe
burns, arthritis, cancer, diabetes, lymphoma, neuroblastoma, leukemia, and
multiple myeloma.
Request for a PDF sample of this report: https://www.imarcgroup.com/stem-
cell-manufacturing-market/requestsample

4. Report Description
Global Stem Cell Manufacturing Market Trends:
The growing prevalence of chronic diseases and degenerative disorders has fueled the demand for innovative therapies,
creating a positive outlook for the market growth. Stem cell-based treatments have demonstrated promising results in
conditions like cardiovascular diseases (CVDs), neurodegenerative disorders, and autoimmune disorders. Moreover, the
increasing need for regenerative therapies that can restore functionality and improve the quality of life for aging
individuals is providing an impetus to the market growth. In addition to this, stem cell therapies hold the potential to
provide personalized and targeted treatment approaches, thus garnering interest from both patients and healthcare
providers. Additionally, the rise in public and private funding for stem cell research has spurred manufacturing
technologies and process optimization advancements, such as induced pluripotent stem cell (iPSC) technology,
facilitating the generation of patient-specif ic stem cells, reducing the risk of immune rejection, and enhancing treatment
efficacy. Furthermore, the integration of advanced bioprocessing techniques and automation in stem cell manufacturing is
encouraging manufacturers to actively invest in cutting-edge technologies to scale up production and improve product
consistency, providing a considerable boost to the market growth. Other factors, including increasing application in tissue
and organ replacement therapies, significant improvement in medical infrastructure, the implementation of various
government initiatives promoting public health, are presenting remunerative growth opportunities f or the market.
Looking forward, the market value is projected to reach US$ 25.0 Billion by 2032, expanding at a CAGR of
7.1% during 2024-2032.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/stem-cell-manufacturing-market

5. Report
Segmentation
Breakup by Product:
• Consumables
o Culture Media
o Others
• Instruments
o Bioreactors and Incubators
o Cell Sorters
o Others
• Stem Cell Lines
o Hematopoietic Stem Cells (HSC)
o Mesenchymal Stem Cells (MSC)
o Induced Pluripotent Stem Cells (iPSC)
o Embryonic Stem Cells (ESC)
o Neural Stem Cells (NSC)
o Multipotent Adult Progenitor Stem Cells

6. Report
Segmentation
Breakup by Application:
• Research Applications
o Life Science Research
o Drug Discovery and Development
• Clinical Application
o Allogenic Stem Cell Therapy
o Autologous Stem Cell Therapy
• Cell and Tissue Banking Applications
Breakup by End User:
• Pharmaceutical & Biotechnology Companies
• Academic Institutes, Research Laboratories and
Contract Research Organizations
• Hospitals and Surgical Centers

7. Report
Segmentation
• Cell and Tissue banks
• Others
Breakup by Region:
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

8. Competitive
Landscape with
Key Players
• Anterogen Co. Ltd.
• Becton Dickinson and Company
• Bio-Rad Laboratories Inc.
• Bio-Techne Corporation
• Corning Incorporated
• FUJIFILM Holdings Corporation
• Lonza Group AG
• Merck KGaA
• Sartorius AG
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.

9. Key Questions
Answered in
the Report
What was the size of the global stem cell manufacturing market in
2023?
What is the expected growth rate of the global stem cell
manufacturing market during 2024-2032?
What are the key factors driving the global stem cell manufacturing
market?
What has been the impact of COVID-19 on the global stem cell
manufacturing market?
What is the breakup of the global stem cell manufacturing market
based on product?
What is the breakup of the global stem cell manufacturing market
based on the application?
What is the breakup of the global stem cell manufacturing market
based on the end user?
What are the key regions in the global stem cell manufacturing
market?
Who are the key players/companies in the global stem cell
manufacturing market?

10. Table of
Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Stem Cell Manufacturing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Consumables
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Culture Media
6.1.2.2 Others
6.1.3 Mark et Forecast
6.2 Instruments
6.2.1 Mark et Trends
6.2.2 Key Segments
6.2.2.1 Bioreactors and Incubators

11. Table of
Contents
6.2.2.2 Cell Sorters
6.2.2.3 Others
6.2.3 Mark et Forecast
6.3 Stem Cell Lines
6.3.1 Mark et Trends
6.3.2 Key Segments
6.3.2.1 Hematopoietic Stem Cells (HSC)
6.3.2.2 Mesenchymal Stem Cells (MSC)
6.3.2.3 Induced Pluripotent Stem Cells (iPSC)
6.3.2.4 Embryonic Stem Cells (ESC)
6.3.2.5 Neural Stem Cells (NSC)
6.3.2.6 Multipotent Adult Progenitor Stem Cells
6.3.3 Mark et Forecast
7 Market Breakup by Application
7.1 Research Applications
7.1.1 Mark et Trends
7.1.2 Key Segments
7.1.2.1 Lif e Science Research
7.1.2.2 Drug Discovery and Development
7.1.3 Mark et Forecast
7.2 Clinical Application
7.2.1 Mark et Trends
7.2.2 Key Segments
7.2.2.1 Allogenic Stem Cell Therapy
7.2.2.2 Autologous Stem Cell Therapy
7.2.3 Mark et Forecast
7.3 Cell and T issue Bank ing Applications
7.3.1 Mark et Trends
7.3.2 Mark et Forecast
For more information, visit :
https://www.imarcgroup.com/stem -cell-manufacturing -
market/toc

12. Disclaimer
© 2023 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the
name of International Market Analysis Research and Consulting (IMARC). No part of this
publication may be reproduced, repackaged, redistributed or resold in whole or in any part.
The publication may also not be used in any form or by and means graphic electronic or
mechanical, including photocopying, recording, taping or by information storage or retrieval,
or by any other form, without the express consent of International Market Analysis Research
and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and
opinion have been based on information and sources believed to be accurate and reliable at
the time of publishing. International Market Analysis Research and Consulting makes no
representation of warranty of any kind as to the accuracy or completeness of any Information
provided. IMARC accepts no liability whatsoever for any loss or damage resulting from
opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of
International Market Analysis Research and Consulting. All other trademarks used in this
publication are registered trademarks of their respective companies.

13. Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com